A detailed history of Steward Partners Investment Advisory, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 11,428 shares of ADMA stock, worth $230,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,428
Previous 1,000 1042.8%
Holding current value
$230,845
Previous $11,000 1972.73%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.21 - $20.03 $116,897 - $208,872
10,428 Added 1042.8%
11,428 $228,000
Q4 2021

Feb 08, 2022

SELL
$1.09 - $1.66 $3,270 - $4,980
-3,000 Reduced 75.0%
1,000 $1,000
Q3 2020

Oct 30, 2020

BUY
$2.04 - $3.74 $6,120 - $11,220
3,000 Added 300.0%
4,000 $10,000
Q2 2019

Jul 25, 2019

BUY
$3.52 - $5.24 $3,520 - $5,240
1,000 New
1,000 $3,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.97B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.